Skip to content

Thinking of Getting a Puppy This Christmas? What You Need to Know

By API User

With Christmas just around the corner, many families are considering adding a furry, four-legged member to the household. According to accredited dog behaviourist, expert force-free trainer and bestselling author Sarah Rutten, the holiday season can be a wonderful time to start life with a new dog, as long as families are prepared for what puppies … Continued

Thinking of Getting a Puppy This Christmas? What You Need to Know

By API User

With Christmas just around the corner, many families are considering adding a furry, four-legged member to the household. According to accredited dog behaviourist, expert force-free trainer and bestselling author Sarah Rutten, the holiday season can be a wonderful time to start life with a new dog, as long as families are prepared for what puppies … Continued

Australian almond outlook – “cracking growth” beyond 2030

By API User

Australia’s almond sector is entering a new era, as it begins large-scale orchard replanting to enable future growth and satisfy increasing local and global appetite for the popular nut, Rabobank says in a newly-released report.   In its Australian Almond Outlook: Replanting for growth beyond 2030, the specialist agribusiness bank’s RaboResearch division says the Australian … Continued

ATO returns over $1 billion in unpaid super to employees

By API User

The Australian Taxation Office (ATO) has released new data, revealing $1.1 billion in unpaid super has been returned to nearly a million individual’s super funds in 2024–25. Deputy Commissioner Ben Kelly said the latest figures show the ATO’s compliance efforts to protect employee’s super entitlements are continuing to pay dividends. ‘We issued over 200,000 proactive reminders and … Continued

Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell Malignancies

By API User

Novel BCL2 inhibitor sonrotoclax monotherapy demonstrates deep and durable clinical responses in R/R MCL and R/R CLL Sonrotoclax in combination with BRUKINSA demonstrated rapid MRD negativity in treatment-naive CLL, regardless of high-risk features SAN CARLOS, Calif.–BUSINESS WIRE– BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data on … Continued

Miltenyi Biomedicine presents primary analysis of the pivotal DALY 2-EU trial for second-line relapsed/refractory large B-cell lymphoma at the 67th American Society of Hematology (ASH) Annual Meeting

By API User

DALY 2-EU results show zamtocabtagene autoleucel (zamto-cel) demonstrated clinically meaningful superiority over chemoimmunotherapy in patients with relapsed/refractory large B-cell lymphoma (r/r LBCL)1 Zamto-cel was well-tolerated in the majority of patients. DALY 2-EU included a high-risk study population, characterized by older age and clinically high-risk disease features A 12-day manufacturing time resulted in a vein-to-vein time … Continued

Social Media Ban, UNSW Experts Available for Comment

By API User

The Australian Government’s new restrictions preventing people under 16 from accessing social media platforms will come into effect on 10 December 2025. The changes require platforms to implement age-verification measures and enforce minimum age requirements.  UNSW experts are available to comment and provide context and analysis on the technical, social, economic and policy considerations of … Continued

TPB announces compliance priorities with a focus on integrity

By API User

The Tax Practitioners Board (TPB) has announced its 2026 compliance priorities to provide greater transparency and clarity to the tax profession. By publishing these priorities for the first time, the TPB aims to promote integrity, support voluntary compliance, and strengthen community confidence in the tax profession. These priorities complement the TPB’s enduring focus areas, which … Continued